345832 Galectin-3C, Human, Recombinant, E. coli

345832
Wyświetl ceny i dostępność

Przegląd

Replacement Information

Tabela kluczowych gatunków

Ceny i dostępność

Numer katalogowy DostępnośćOpakowanie Ilość/opak. Cena netto Ilość
345832-100UG
Pobieram informacje o dostępności...
Niedostępny w magazynie PLNiedostępny w magazynie PL
Dostępny w magazynie 
Wycofano
Dostępna ograniczona ilość
Dostępność będzie potwierdzona
    Remaining : Will advise
      Remaining : Will advise
      Doradzimy
      Skontaktuj się z Zespołem Obsługi Klienta
      Contact Customer Service

      Ampulka plastikowa 100 μg
      Pobieranie ceny...
      Nie udało się pobrać ceny
      Minimum Quantity needs to be mulitiple of
      Na zapytanie Więcej informacji
      Zapisano ()
       
      Poproś o podanie ceny netto
      Description
      OverviewRecombinant, human galectin-3 expressed in E. coli and subsequently cleaved with Clostridium histolyticum collagenase type VII to yield galectin-3C. The resulting galectin-3C is purified by affinity chromatography. Galectin-3C is a truncated form of galectin-3 that contains the carbohydrate binding domain but lacks the 107 amino acids at the N-terminus of galectin-3. It is suggested to play a key role in autoimmune diseases, allergic reactions, inflammation, tumor cell metastasis, atherosclerosis, and diabetes.
      Catalogue Number345832
      Brand Family Calbiochem®
      References
      ReferencesHoyer K.K., et al. 2004. Am. J. Pathol. 164, 893.
      John C.M., et al. 2003. Clin. Cancer Res. 9, 2374.
      Iurisci, I., et al. 2000. Clin Cancer Res 6, 1389.
      Van Den Brule, F. A., et al. 2000. Int. J. Cancer 89, 361.
      Inohara, H. 1999. Cancer 85, 2475.
      Nakamura, M., et al. 1999. Int. J. Oncol. 15, 143.
      Idikio, H., et al. 1998. Int. J. Oncol. 12, 1287.
      Ochieng, J., et al. 1998. Biochim. Biophys. Acta. 1379 97.
      Castronovo, V., et al. 1996. J. Pathol. 179, 43.
      Liu, F.T., et al. 1996. Biochemistry 35 6073.
      Schoeppner, H. L., et al. 1995. Cancer 75, 2818.
      Massa, S.M., et al. 1993. Biochemistry 32, 260.
      Oda, Y., et al. 1991. Gene 99, 279.
      Product Information
      FormLyophilized
      FormulationLyophilized from deionized water, 2µg lactose/µg lectin.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥95% by SDS-PAGE
      Physicochemical Information
      ContaminantsEndotoxin: ≤ 1 EU/µg protein
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Blue Ice Only
      Toxicity Standard Handling
      Storage -20°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions (in the presence of a molar excess of lactose) are stable for up to 4 months at -20°C. For use in carbohydrate binding assays the solution should be dialyzed to remove the lactose stabilizer.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications

      Documentation

      Galectin-3C, Human, Recombinant, E. coli MSDS

      Title

      Safety Data Sheet (SDS) 

      Galectin-3C, Human, Recombinant, E. coli Certificates of Analysis

      TitleLot Number
      345832

      References

      Przegląd literatury
      Hoyer K.K., et al. 2004. Am. J. Pathol. 164, 893.
      John C.M., et al. 2003. Clin. Cancer Res. 9, 2374.
      Iurisci, I., et al. 2000. Clin Cancer Res 6, 1389.
      Van Den Brule, F. A., et al. 2000. Int. J. Cancer 89, 361.
      Inohara, H. 1999. Cancer 85, 2475.
      Nakamura, M., et al. 1999. Int. J. Oncol. 15, 143.
      Idikio, H., et al. 1998. Int. J. Oncol. 12, 1287.
      Ochieng, J., et al. 1998. Biochim. Biophys. Acta. 1379 97.
      Castronovo, V., et al. 1996. J. Pathol. 179, 43.
      Liu, F.T., et al. 1996. Biochemistry 35 6073.
      Schoeppner, H. L., et al. 1995. Cancer 75, 2818.
      Massa, S.M., et al. 1993. Biochemistry 32, 260.
      Oda, Y., et al. 1991. Gene 99, 279.
      Data Sheet

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-June-2008 RFH
      DescriptionRecombinant, human galectin-3 expressed in E. coli and subsequently cleaved with Clostridium histiolyticum collagenase type VII to yield galectin-3C. The resulting galectin-3C is purified by affinity chromatography. Galectin-3C is a truncated form of galectin-3 that contains the carbohydrate binding domain but lacks the 107 amino acids at the N-terminus of galectin-3. It is suggested to play a key role in autoimmune diseases, allergic reactions, inflammation, tumor cell metastasis, atherosclerosis, and diabetes.
      FormLyophilized
      FormulationLyophilized from deionized water, 2µg lactose/µg lectin.
      Purity≥95% by SDS-PAGE
      ContaminantsEndotoxin: ≤ 1 EU/µg protein
      SolubilitySterile PBS (1 mg/ml)
      Storage -20°C
      Avoid freeze/thaw
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions (in the presence of a molar excess of lactose) are stable for up to 4 months at -20°C. For use in carbohydrate binding assays the solution should be dialyzed to remove the lactose stabilizer.
      Toxicity Standard Handling
      ReferencesHoyer K.K., et al. 2004. Am. J. Pathol. 164, 893.
      John C.M., et al. 2003. Clin. Cancer Res. 9, 2374.
      Iurisci, I., et al. 2000. Clin Cancer Res 6, 1389.
      Van Den Brule, F. A., et al. 2000. Int. J. Cancer 89, 361.
      Inohara, H. 1999. Cancer 85, 2475.
      Nakamura, M., et al. 1999. Int. J. Oncol. 15, 143.
      Idikio, H., et al. 1998. Int. J. Oncol. 12, 1287.
      Ochieng, J., et al. 1998. Biochim. Biophys. Acta. 1379 97.
      Castronovo, V., et al. 1996. J. Pathol. 179, 43.
      Liu, F.T., et al. 1996. Biochemistry 35 6073.
      Schoeppner, H. L., et al. 1995. Cancer 75, 2818.
      Massa, S.M., et al. 1993. Biochemistry 32, 260.
      Oda, Y., et al. 1991. Gene 99, 279.